Xeruborbactam/Ceftibuten

N/A

Report date: 2026/04/21 20:00:18

Base Information

Drug NameXeruborbactam/Ceftibuten
Drug Alias NameS-743229
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBeta Lactamase inhibitorsBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBeta LactamaseBacterial penicillin-binding protein
Therapy Area/IndicationsPyelonephritisUrinary Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsYes XeruborbactamCeftibuten Dihydrate
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShionogi & Co Ltd
Inactive CompaniesN/A
Active IndicationsPyelonephritisUrinary Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A